Polarean Company Profile
✉ Email this page to a colleague
What is the competitive landscape for POLAREAN
POLAREAN has one approved drug.
There are two US patents protecting POLAREAN drugs.
Summary for Polarean
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Polarean
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | 11,052,161 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | 10,583,205 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Polarean Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3107583 | ⤷ Start Trial |
| Hungary | E045999 | ⤷ Start Trial |
| Australia | 2015218883 | ⤷ Start Trial |
| China | 106456808 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2015127208 | ⤷ Start Trial |
| European Patent Office | 3107583 | ⤷ Start Trial |
| Canada | 2940109 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
